Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Published on May 1, 2021in The Lancet Gastroenterology & Hepatology14.789
· DOI :10.1016/S2468-1253(21)00014-5
Brigida Barberio7
Estimated H-index: 7
(UNIPD: University of Padua),
Mohammad Mahdi Zamani12
Estimated H-index: 12
(Tehran University of Medical Sciences)
+ 2 AuthorsAlexander C. Ford86
Estimated H-index: 86
(University of Leeds)
Sources
Abstract
Summary Background Inflammatory bowel disease (IBD) is a lifelong condition with no cure. Patients with IBD might experience symptoms of common mental disorders such as anxiety and depression because of bidirectional communication via the gut–brain axis and chronicity of symptoms, and because of impaired quality of life and reduced social functioning. However, uncertainties remain about the magnitude of this problem. We aimed to assess prevalence of symptoms of anxiety or depression in adult patients with IBD. Methods In this systematic review and meta-analysis, we searched MEDLINE, Embase, Embase Classic, and PsycINFO for papers published from inception to Sept 30, 2020, reporting observational studies that recruited at least 100 adult patients with IBD and that reported prevalence of symptoms of anxiety or depression according to validated screening instruments. We excluded studies that only used a structured interview to assess for these symptoms and studies that did not provide extractable data. We extracted data from published study reports and calculated pooled prevalences of symptoms of anxiety and depression, odds ratios (OR), and 95% CIs. Findings Of 5544 studies identified, 77 fulfilled the eligibility criteria, including 30 118 patients in total. Overall, pooled prevalence of anxiety symptoms was 32·1% (95% CI 28·3–36·0) in 58 studies (I2=96·9%) and pooled prevalence of depression symptoms was 25·2% (22·0–28·5) in 75 studies (I2=97·6%). In studies that reported prevalence of anxiety or depression in patients with Crohn's disease and ulcerative colitis within the same study population, patients with Crohn's disease had higher odds of anxiety symptoms (OR 1·2, 95% CI 1·1–1·4) and depression symptoms (1·2, 1·1–1·4) than patients with ulcerative colitis. Overall, women with IBD were more likely to have symptoms of anxiety than were men with IBD (pooled prevalence 33·8% [95% CI 26·5–41·5] for women vs 22·8% [18·7–27·2] for men; OR 1·7 [95% CI 1·2–2·3]). They were also more likely to have symptoms of depression than men were (pooled prevalence 21·2% [95% CI 15·4–27·6] for women vs 16·2% [12·6–20·3] for men; OR 1·3 [95% CI 1·0–1·8]). The prevalence of symptoms of anxiety (57·6% [95% CI 38·6–75·4]) or depression (38·9% [26·2–52·3]) was higher in patients with active IBD than in patients with inactive disease (38·1% [30·9–45·7] for anxiety symptoms and 24·2% [14·7–35·3] for depression symptoms; ORs 2·5 [95% CI 1·5–4·1] for anxiety and 3·1 [1·9–4·9] for depression). Interpretation There is a high prevalence of symptoms of anxiety and depression in patients with IBD, with up to a third of patients affected by anxiety symptoms and a quarter affected by depression symptoms. Prevalence was also increased in patients with active disease: half of these patients met criteria for anxiety symptoms and a third met criteria for depression symptoms. Encouraging gastroenterologists to screen for and treat these disorders might improve outcomes for patients with IBD. Funding None.
📖 Papers frequently viewed together
2 Citations
157 Citations
8 Authors (Xin Gao, ..., Yan Zhang)
References113
Newest
#1Taryn J. Lores (University of Adelaide)H-Index: 2
#1Taryn Lores (University of Adelaide)H-Index: 1
Last. Jane M. Andrews (University of Adelaide)H-Index: 55
view all 8 authors...
Abstract Background & Aims Inflammatory bowel diseases (IBD) are associated with high psychosocial burden and economic cost. Integrating psychological care into routine management might lead to savings. We performed a 2-year investigation of the effects of integrated psychological care in reducing healthcare use and costs. Methods We performed a prospective study of 335 adult patients treated at a hospital-based IBD service in Australia. Participants were recruited between September 2015 and Aug...
6 CitationsSource
#1Eva Szigethy (University of Pittsburgh)H-Index: 38
#2Sean M. Murphy (Cornell University)H-Index: 17
Last. John I. Allen (UM: University of Michigan)H-Index: 18
view all 9 authors...
BACKGROUND: Mental health diagnoses (MHDs) were identified as significant drivers of inflammatory bowel disease (IBD)-related costs in an analysis titled "Cost of Care Initiative" supported by the Crohn's & Colitis Foundation. In this subanalysis, we sought to characterize and compare IBD patients with and without MHDs based on insurance claims data in terms of demographic traits, medical utilization, and annualized costs of care. METHODS: We analyzed the Optum Research Database of administrativ...
4 CitationsSource
#1Jonathan Blackwell (St George's, University of London)H-Index: 4
#2Sonia Saxena (Imperial College London)H-Index: 56
Last. Richard PollokH-Index: 28
view all 8 authors...
Objective Depression is a potential risk factor for developing IBD. This association may be related to GI symptoms occurring before diagnosis. We aimed to determine whether depression, adjusted for pre-existing GI symptoms, is associated with subsequent IBD. Design We conducted a nested case–control study using the Clinical Practice Research Datalink identifying incident cases of UC and Crohn’s disease (CD) from 1998 to 2016. Controls without IBD were matched for age and sex. We measured exposur...
4 CitationsSource
#1Adi Eindor Abarbanel (TAU: Tel Aviv University)H-Index: 1
#2Timna Naftali (Meir Medical Center)H-Index: 17
Last. Efrat Broide (TAU: Tel Aviv University)H-Index: 23
view all 11 authors...
Introduction Anxiety and depression are common disturbances in patients with inflammatory bowel diseases (IBD), and were found to impact the disease course. Illness perceptions (IPs), self-efficacy (SE) and sense of coherence (SOC) are important psychological functions, used by the individual to cope with his chronic disease. Aims to investigate the association of IP, SE and SOC on anxiety and depression among patients with IBD. Patients and methods Patients filled questionnaires including: demo...
1 CitationsSource
#1Nienke Z. Borren (Harvard University)H-Index: 8
#2William Tan (Harvard University)H-Index: 5
Last. Ashwin N. Ananthakrishnan (Harvard University)H-Index: 74
view all 8 authors...
BACKGROUNDS AND AIMS: Fatigue is prevalent in patients with inflammatory bowel diseases [IBD]. Biologic therapy is effective in achieving symptomatic and endoscopic remission, but its impact on fatigue is less well established. Our aim is to define the longitudinal trajectory of fatigue over 1 year in patients initiating biologic therapy. METHODS: This prospective cohort enrolled patients diagnosed with Crohn's disease [CD] or ulcerative colitis [UC] initiating biologic therapy with infliximab, ...
8 CitationsSource
#1Michel Adamina (University of Basel)H-Index: 20
#1Joana TorresH-Index: 12
Last. Gionata Fiorino (Humanitas University)H-Index: 51
view all 46 authors...
This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of ...
133 CitationsSource
#1Rosellina Margherita Mancina (University of Gothenburg)H-Index: 24
#2Raffaele PagnottaH-Index: 1
Last. Rocco SpagnuoloH-Index: 7
view all 8 authors...
Background and Objectives: Nursing management in Inflammatory Bowel Disease (IBD) is focused on global patient care. Starting from basic knowledge of diagnostic and therapeutic management, nurses can assess the impact of IBD on patients’ quality of life not only at the physical level, but also at the psychological, social, and emotional levels. The aim of this study was to evaluate the impact of gastrointestinal symptoms on psychosocial changes in IBD patients in remission through nursing-led Pa...
6 CitationsSource
#1Firdevs Topal (Izmir Kâtip Çelebi University)H-Index: 7
#2Hakan Çamyar (Izmir Kâtip Çelebi University)H-Index: 1
Last. Emine Özlem Gür (Izmir Kâtip Çelebi University)H-Index: 4
view all 6 authors...
Background. Beyond the medical treatment in inflammatory bowel disease (IBD), there are other issues which influence the quality of life adversely. The aim of this study was to determine the impact of the IBD patients’ illness on working and education life. Method. The participants were invited to participate in the online survey from the Turkish Crohn’s and Ulcerative Colitis Patient Association network. The data was analysed and then discussed to improve the health-related quality of working a...
1 CitationsSource
#1Yu Tang (Sichuan University)H-Index: 2
#2Li Zhao (Sichuan University)H-Index: 8
Last. Yan Zhang (Sichuan University)H-Index: 24
view all 5 authors...
BACKGROUND: Crohn's disease (CD) is strongly associated with depression, but the mechanisms underlying this relationship are not fully understood. Recently, neuroimmunological studies have demonstrated that proinflammatory monocytes/macrophages play a key role in the pathogenesis of depression. The present study investigates monocyte/macrophage phenotypes and plasma cytokine levels in CD. METHODS: Eligible CD patients were divided into nondepressed and depressed groups according to Hospital Anxi...
4 CitationsSource
#1Kylee Lewis (UM: University of Manitoba)H-Index: 2
#2Ruth Ann Marrie (UM: University of Manitoba)H-Index: 69
Last. James J. MarriottH-Index: 15
view all 8 authors...
BACKGROUND: Inflammatory bowel disease (IBD) is associated with a high prevalence of comorbid depressive and anxiety disorders. A significant proportion of IBD patients with comorbid psychiatric disorders remain undiagnosed and untreated, but factors associated with diagnosis are unknown. We evaluated the prevalence of undiagnosed depression and anxiety in an IBD cohort, along with the associated demographic and clinical characteristics. METHODS: We obtained data from the enrollment visit of a c...
22 CitationsSource
Cited By3
Newest
#1Keeley M. Fairbrass (University of Leeds)H-Index: 2
#2David J. Gracie (University of Leeds)H-Index: 16
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 0 authors...
BACKGROUND Psychological co-morbidity is more common in patients with inflammatory bowel disease (IBD), compared with the general population, but little is known about the cumulative effect of increasing psychological burden on disease behaviour. AIMS To examine the effect of psychological co-morbidity on inflammatory bowel disease in a longitudinal follow-up study. METHODS We collected complete demographic, symptom and psychological co-morbidity data (anxiety, depression and somatisation scores...
Source
#1Silvio Danese (Humanitas University)H-Index: 100
#2Tommaso Lorenzo Parigi (Humanitas University)H-Index: 6
Last. Subrata Ghosh (NUI: National University of Ireland)
view all 4 authors...
Source
#1Linda Cingolani (UNIPD: University of Padua)H-Index: 2
#2Brigida Barberio (UNIPD: University of Padua)H-Index: 7
Last. Edoardo Savarino (UNIPD: University of Padua)H-Index: 60
view all 14 authors...
To date, data on effectiveness and safety of Adalimumab (ADA) biosimilars in inflammatory bowel diseases (IBDs) are lacking. Therefore, we aimed to verify the ability of ABP501 and SB5 to maintain the clinical and biochemical response induced by the ADA originator, after switching to them. We prospectively analyzed data collected from 55 patients with IBD who switched to ABP501, and 25 patients with IBD who switched to SB5, from ADA originator at four IBD Units between 2018 and 2020. In addition...
Source
#1Laurie Keefer (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 40
Source
#1Davide Massimi (UNIPD: University of Padua)H-Index: 3
#2Brigida Barberio (UNIPD: University of Padua)H-Index: 7
Last. Renata D'Incà (UNIPD: University of Padua)H-Index: 60
view all 0 authors...
Background:Current literature still lacks studies evaluating the effectiveness and safety of switching from Infliximab originator to SB2 biosimilar in Inflammatory Bowel Diseases (IBDs). We aimed t...
Source